Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 0.64 |
| ▸ | CCR8 | P51685 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 5/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.64 |
| ▸ | CCR5 | P51681 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | HTT | P42858 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | MMP2 | P08253 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | GMNN | O75496 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | MMP9 | P14780 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | MMP8 | P22894 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL68795 | 0.82 | CCR1 (0.39) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL29354015 | 0.80 | CCR1 (1.00) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL29367277 | 0.80 | CCR1 (1.00) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL8845760 | 0.80 | CCR1 (1.00) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL8312 | 0.80 | CCR1 (1.00) | CCR1CCR8LMNAKDM4ECCR5 | |
| SCHEMBL24930 | 0.78 | LMNA (0.62) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL22982126 | 0.78 | CCR1 (0.94) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL21044608 | 0.78 | CCR1 (0.94) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL21300488 | 0.78 | CCR1 (0.94) | CCR1CCR8LMNAKDM4ECCR5 | |
| Phenanthroline SCHEMBL22462277 | 0.78 | CCR1 (0.94) | CCR1CCR8LMNAKDM4ECCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1649 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190901-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-06-13 | — | — | US | claimed |
| EP-3303605-B1 | MULTI-MEDIATOR REAGENT FORMULATIONS FOR USE IN ELECTROCHEMICAL DETECTION | OMNI BIOMEDICAL INC (US) | 2024-04-03 | — | — | EP | claimed |
| WO-2023213712-A1 | ORGANIC LIGHT EMITTING DIODE AND DEVICE COMPRISING THE SAME | NOVALED GMBH (DE) | 2023-11-09 | — | — | WO | claimed |
| EP-4273948-A1 | ORGANIC LIGHT EMITTING DIODE AND DEVICE COMPRISING THE SAME | Novaled GmbH (DE) | 2023-11-08 | — | — | EP | claimed |
| US-20230139051-A1 | BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-05-04 | — | — | US | claimed |
| US-11608311-B2 | Nitrogen-containing compound, organic electroluminescent device, and electronic apparatus | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-03-21 | — | — | US | claimed |
| CN-115677443-A | Method for constructing 1, 4-diketone compound by olefin 1, 2-dicarbonylation | 中国科学院理化技术研究所 | 2023-02-03 | — | — | CN | claimed |
| US-20220388944-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-12-08 | — | — | US | claimed |
| CN-115029127-A | Organic electroluminescent material composition and application thereof | 北京云基科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-114989179-A | Organic compound, and organic electroluminescent device and electronic device using the same | 陕西莱特光电材料股份有限公司 | 2022-09-02 | — | — | CN | claimed |
| EP-1084132-A1 | REDOX REVERSIBLE IMIDAZOLE-OSMIUM COMPLEX CONJUGATES | Roche Diagnostics Corporation (US) | 2001-03-21 | — | — | EP | claimed |
| EP-1084409-A1 | METHOD AND DEVICE FOR ELECTROCHEMICAL IMMUNOASSAY OF MULTIPLE ANALYTES | Roche Diagnostics Corporation (US) | 2001-03-21 | — | — | EP | claimed |
| EP-0813608-A4 | OSMIUM-CONTAINING REDOX MEDIATOR | ROCHE DIAGNOSTICS CORP (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1999062918-A1 | REDOX REVERSIBLE IMIDAZOLE-OSMIUM COMPLEX CONJUGATES | ROCHE DIAGNOSTICS CORPORATION (US) | 1999-12-09 | — | — | WO | claimed |
| WO-1999063346-A1 | METHOD AND DEVICE FOR ELECTROCHEMICAL IMMUNOASSAY OF MULTIPLE ANALYTES | ROCHE DIAGNOSTICS CORPORATION (US) | 1999-12-09 | — | — | WO | claimed |
| EP-0885868-A1 | Oxidation-process for the production of aldehydes and ketones in the presence of nitrogen-containing compounds | Consortium für elektrochemische Industrie GmbH (DE) | 1998-12-23 | — | — | EP | claimed |
| US-5846702-A | Reagent including an osmium-containing redox mediator | BOEHRINGER MANNHEIM CORPORATION (US) | 1998-12-08 | — | — | US | claimed |
| EP-0813608-A1 | OSMIUM-CONTAINING REDOX MEDIATOR | BOEHRINGER MANNHEIM CORPORATION (US) | 1997-12-29 | — | — | EP | claimed |
| US-5589326-A | FOR ELECTROCHEMICAL BIOSENSORS | BOEHRINGER MANNHEIM CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| WO-1996025514-A1 | OSMIUM-CONTAINING REDOX MEDIATOR | BOEHRINGER MANNHEIM CORPORATION (US) | 1996-08-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139051-A1 | BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF | TSPO, XDH, TARS2 | CCR1 4798/4885CCR8 4392/4885LMNA 614/4885 |
| US-20240190901-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ODC1 | CCR1 4653/4885CCR8 4209/4885LMNA 1381/4885 |
| US-11608311-B2 | Nitrogen-containing compound, organic electroluminescent device, and electronic apparatus | NOM1, MNS1, NOS1 | CCR1 2097/4885CCR8 4029/4885LMNA 3897/4885 |
| US-20220388944-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | NOM1, MNS1, NOS1 | CCR1 2097/4885CCR8 4029/4885LMNA 3897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.